- Report
- April 2025
- 120 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- August 2025
- 193 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- March 2025
- 182 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- September 2025
- 369 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- August 2025
- 188 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 190 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 182 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 180 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 195 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- September 2025
- 349 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 193 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- June 2025
- 280 Pages
Global
From €4362EUR$4,995USD£3,790GBP
- Report
- June 2025
- 90 Pages
United States
From €3450EUR$3,950USD£2,997GBP
- Report
- January 2024
- 121 Pages
Global
From €4061EUR$4,650USD£3,528GBP
- Report
- June 2021
- 142 Pages
Global
From €4803EUR$5,500USD£4,173GBP
- Report
- January 2024
- 110 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- May 2024
- 169 Pages
Global
From €2183EUR$2,500USD£1,897GBP
- Report
- May 2024
- 182 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- July 2024
- 105 Pages
Global
From €4148EUR$4,750USD£3,604GBP

Cell reprogramming is a biotechnology process that involves the conversion of a cell from one type to another. It is used to create induced pluripotent stem cells (iPSCs) from adult cells, which can then be used to study diseases, develop new treatments, and create personalized medicine. Cell reprogramming is also used to create cell models of diseases, which can be used to study the underlying mechanisms of the disease and develop new therapies. Additionally, cell reprogramming can be used to create cell-based therapies, such as gene therapy, which can be used to treat genetic diseases.
Cell reprogramming is a rapidly growing field, with many companies investing in the technology. Some of the companies in the market include Ginkgo Bioworks, Cellular Dynamics International, Fate Therapeutics, and Pluristem Therapeutics. Show Less Read more